Variable | Survival | Death | P value |
---|---|---|---|
Sample size (n) | 32 (69.6Â %) | 14 (30.4Â %) | Â |
Age (years) (n = 46) | 51.5 (41.5–58.0) | 54.7 (48.2–68.2) | 0.118 |
Gender | Â | Â | 1.000 |
 Male (n = 35) | 24 (68.6 %) | 11 (31.4 %) |  |
 Female (n = 11) | 8 (72.7 %) | 3 (27.3 %) |  |
Risk factors | |||
 Hypertension (n = 21) | 14 (43.8 %) | 7 (50.0 %) | 0.755 |
 DM (n = 13) | 7 (21.9 %) | 6 (42.9 %) | 0.171 |
 CAD (n = 11) | 6 (18.8 %) | 5 (35.7 %) | 0.269 |
 Smoking (n = 9) | 7 (21.9 %) | 2 (14.3 %) | 0.701 |
 Dialysis (n = 5) | 1 (3.1 %) | 4 (28.6 %) | 0.078 |
 Pre-ECMO CPR (n = 13) | 10 (31.3 %) | 3 (21.4 %) | 0.724 |
 CPR during ECMO (n = 20) | 11 (34.4 %) | 9 (64.3 %) | 0.105 |
Diagnosis | |||
 AMI (n = 24) | 16 (50.0 %) | 8 (57.1 %) | 0.754 |
 DCMP (n = 12) | 7 (21.9 %) | 5 (35.7 %) | 0.467 |
 Myocarditis (n = 6) | 6 (18.8 %) | 0 (0.0 %) | 0.157 |
 Other (n = 4) | 3 (9.4 %) | 1 (7.1 %) | 1.000 |
Heart rate (BPM) (n = 42) | 116 (88–138) | 96 (66–121) | 0.196 |
Systolic blood pressure (mmHg) (n = 40) | 90 (74–101) | 93 (76–113) | 0.902 |
Diastolic blood pressure (mmHg) (n = 40) | 57 (47–67) | 53 (44–64) | 0.435 |
pH (n = 45) | 7.41 (7.30–7.48) | 7.23 (7.13–7.39) | 0.066 |
PaCO2 (mmHg) (n = 45) | 32 (23–39) | 35 (27–46) | 0.455 |
PaO2 (mmHg) (n = 45) | 83 (56–156) | 108 (60–222) | 0.313 |
HCO3 (mmol/L) (n = 45) | 19.3 (15.9–24.0) | 17.6 (12.7–19.3) | 0.107 |
Lactate (mmol/L) (n = 43) | 6.7 (3.0–9.7) | 10.9 (3.3–18) | 0.260 |
Inotropic equivalent (μg/kg/min) (n = 34) | 17.5 (8.2–25.2) | 23.3 (18.7–34.4) | 0.077 |
WBC (K/µL) (n = 46) | 12.9 (8.7–15.4) | 12.3 (9.1–18.4) | 0.645 |
Granulocytes (% of total WBC) (n = 46) | 72.8 (40.1–82.1) | 60.0 (42.2–80.8) | 0.856 |
Lymphocytes (% of total WBC) (n = 46) | 17.3 (9.0–51.5) | 34.2 (11.1–50.1) | 0.612 |
Monocytes (% of total WBC) (n = 46) | 4.0 (3.2–6.6) | 3.9 (2.8–6.4) | 0.772 |
CD14+ CD16+ (% of monocytes) (n = 46) | 64.4 (46.4–82.2) | 60.7 (43.7–71.6) | 0.314 |